Clearing the Path: How Regulatory Transparency Supports UK Leadership in Advanced Therapy Clinical Trials

In this article for the 2026 CCRA Industry Yearbook, Jan Mothes, our Regulatory Affairs Lead, explores how clearer regulatory pathways, early engagement and greater transparency can help sponsors navigate clinical trial start-up.

Jan also highlights our Clinical Trial Start-Up Tool, an interactive roadmap bringing together key regulatory requirements and processes for ATMP clinical trials in the UK.

Read the article

https://cgt.ams3.cdn.digitaloceanspaces.com/Screenshot-2026-11-05-170055.png